Thommi G, Bell G, Liu J, Nugent K
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock 79430.
South Med J. 1991 Jul;84(7):828-31. doi: 10.1097/00007611-199107000-00004.
Invasive pulmonary aspergillosis is a well-recognized complication in immunocompromised patients, especially those with neutropenia. We report four cases of invasive pulmonary aspergillosis in patients whose main underlying disease was chronic obstructive pulmonary disease (COPD). Two patients had an acute fatal course, one had chronic necrotizing pulmonary aspergillosis ending in an acute fatal course, and the other had a semiacute disease that responded to amphotericin B. Autopsy on three patients showed invasive pulmonary aspergillosis in both lungs, and tissue invasion was documented by transbronchial biopsy in the patient who survived. Retrospective review of all cultures that grew Aspergillus species from bronchoscopic specimens showed no false-positive results, and this procedure proved to be the most useful maneuver in making the diagnosis. Invasive pulmonary aspergillosis should be in the differential diagnosis in patients with COPD and unexplained pulmonary infiltrates.
侵袭性肺曲霉病是免疫功能低下患者,尤其是中性粒细胞减少患者中一种公认的并发症。我们报告了4例以慢性阻塞性肺疾病(COPD)为主要基础疾病的侵袭性肺曲霉病患者。2例患者病程呈急性且致命,1例为慢性坏死性肺曲霉病,最终病程转为急性且致命,另1例为半急性疾病,对两性霉素B治疗有反应。3例患者的尸检显示双肺均有侵袭性肺曲霉病,存活患者经支气管活检证实有组织侵袭。对支气管镜标本中培养出曲霉菌种的所有培养物进行回顾性分析,结果显示无假阳性,该检查方法被证明是诊断该病最有用的手段。对于患有COPD且有无法解释的肺部浸润的患者,侵袭性肺曲霉病应列入鉴别诊断。